Topics

Millendo Picks Poxel’s Arbet-Engels for Chief Medical Officer Post

14:18 EST 12 Feb 2020 | Xconomy

Millendo Therapeutics (NASDAQ: MLND) has appointed Christophe Arbet-Engels to serve as its chief medical officer, the same position he held most recently at Poxel Pharmaceuticals. Arbet-Engels’s experience also includes positions at Biogen (NASDAQ: BIIB), Boehringer Ingelheim, Roche, Merck (NYSE: MRK), Aventis and Ligand Pharmaceuticals (NASDAQ: LGND). Millendo’s most advanced drug candidate, livoletide, is being developed […]

Original Article: Millendo Picks Poxel’s Arbet-Engels for Chief Medical Officer Post

NEXT ARTICLE

More From BioPortfolio on "Millendo Picks Poxel’s Arbet-Engels for Chief Medical Officer Post"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...